Erythrocytes as carrier for prednisolone: In vitro andin vivo evaluation

Pakistan Journal of Pharmaceutical Sciences

Volumn 23, Issue 2, 2010, Pages 194-200

  Shavi, Gopal V ^a,b   Doijad, Rajendra C ^a   Deshpande, Praful B ^a   Manvi, F V ^a   Meka, Sreenivasa Reddy ^b   Udupa, Nayanabhirama ^b   Omprakash, R ^a   Dhirendra, K ^a  

^a K L E S S COLLEGE OF PHARMACY   (India)

^b MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Dimethylsulphoxide; Glutaraldehyde; Prednisolone; Preswell dilution technique; Resealed erythrocytes; Tissue distribution; Zero order release kinetics

Indexed keywords

DIMETHYL SULFOXIDE; DRUG CARRIER; GLUTARALDEHYDE; HEMOGLOBIN; HYPOTONIC SOLUTION; PREDNISOLONE; SODIUM CHLORIDE;

ARTICLE; CONCENTRATION (PARAMETERS); CROSS LINKING; DILUTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; ERYTHROCYTE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; KINETICS; LIVER; LUNG; NORMAL HUMAN; OSMOTIC FRAGILITY; SPLEEN; TISSUE DISTRIBUTION;

CROSS-LINKING REAGENTS; DIMETHYL SULFOXIDE; DRUG CARRIERS; DRUG COMPOUNDING; DRUG EVALUATION, PRECLINICAL; ERYTHROCYTES; GLUTARAL; HEMOGLOBINS; HUMANS; OSMOTIC FRAGILITY; OSMOTIC PRESSURE; PREDNISOLONE; TISSUE DISTRIBUTION;

EID: 77951744861     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. nd Revised and Expanded edn., Marcel Dekker, New York, pp.538-559.
2. Dale GL, Villacorte DG and Beutler E (1997). High yield entrapment of proteins into erythrocytes, 18 (2), 220-225.
3. Dhir SS and Bhaskaran S (1995). Resealed erythrocytes as carriers for salbutamol sulphate. Ind. J. Pharm. Sci., 57(6): 240-242.
4. Eichler HG, Ramies H, Bauer K, Korn A and Bacher S and Gasic S (1986). Survival of Gentamicin loaded carrier erythrocytes in healthy human volunteers. Eur. J. Clin. Invest. 16(1): 39-42.
5. Gothoskar AV (2004 ). Resealed erythrocytes: A review. Pharm. Tech., 1-6.
6. Gutierrez Millan C, Sayalero Marinero ML, Zarzuelo Castaneda A and Lanao JM (2004a). Drug, enzyme and peptide delivery using erythrocytes as carriers. J. Control Rel. 95: 27-49.
7. Hamidi M and Tajerzadeh H (2000). Evaluation of hypotonic preswelling method for encapulation of enalaprilat in intact human erythrocytes. Drug Development and Industrial Pharmacy, 26(12): 1247-1257. (Pubitemid 32037421)
8. Jain S and Jain NK (1997). Engineered erythrocytes as drug delivery system. Ind. J. Pharm. Sci., 59(6): 275-281.
9. Khar RK and Diwan M (2001). Targeted delivery of drugs. In: Jain NK (editor). Advances in controlled and novel drug delivery. CBS Publishers and Distributors, New Delhi, pp.420-456.
10. Lewis DA and Alpar OH (1984). Therapeutic possibilities of drugs encapsulated in erythrocytes. Int. J. Pharm., 22: 137-146.
11. Lynch WE and Sartino GP and Chaffar A (1980). Erythrocytes as carriers of chemotherapeutuic agents for targeting the reticuloendothelial system. Am. J. Hematol., 9(3): 249-259.
12. Magnani M, Rossi L, Ascenzo M, Panzani I, Bigi L and Zanella A (1998). Erythrocyte engineering for drug delivery and targeting. Biotechnol. Appl.Biochem., 28(1): 1-6. (Pubitemid 28369899)
13. Mishra PRand Jain NK (2002). Biotin methroxate loaded erythrocytes for enhanced liver uptake. A study on rat. Int. J. Pharm., 231(2): 145-153.
14. Mishra PR, Jain S and Jain NK (1996). Engineered erythrocytes as a carrier for ciprofloxacin. Drug Delivery, 3: 239-244.
15. Murthy RSR, Soni NH and Sawant KK (2001). Investigation on resealed erythrocytes as carriers for 5-flurouracil. Ind. J. Pharm. Sci., 63(2): 105-109.
16. Nicholas B (1995). Retrometabolic approaches to drug targeting. Membrane and Barriers. In: Rapaka RS (editor). NIH Publications, pp.1-6.
17. Noel-Hocquet S, Jabbouri S, Lazar S, Maunier JC, Guillaumet C and Ropars C (1992). Erythrocytes as carriers of new anti-opiod prodrugs: In vitro studies. In: Advances in Experimental Medicine and Biology, vol.326: The use of resealed erythrocytes as carriers and bioreactors. Magnani M and DeLoach JR (Eds.), Pslenum Press, New York.
18. Ogiso T, Iwaki M and Othori A (1985). Encapsulation of dexamthasone in rabbit erythrocytes, the disposotion in circulation and anti-inflammatory effect. J. Pharmacobiodyn, 8(12): 1032-1040.
19. Pinilla M, Jordan JA, Danz JC and Luque L (1994). In vitro stability properties of cross-linked red blood cells. Adv. Biosci., 92: 7-16.
20. Richieri GV and Mel CH (1985). Temperature effects on osmotic fragility, and the erythrocyte membrane. Biochemicact Biophysica Acta (BBA) Biomembranes, 813: 41-50. (Pubitemid 15142270)
21. Rossi I, Serafini S, Cappellacci L, Balestra E, Brandi G, Schiavano GF, Franchetti P, Grifantini M, Perno C, Magnani M (2001). Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simples virus. J. Antimicrob. Chemother., 47: 819-827. (Pubitemid 32519830)
22. Sanz S, Lizano C, Luque J and Pinilla M (1999). In vitro and in vivo study of glutumate dehydrogenase encapsulated into mouse erythrocytes by a hypotonic dialysis procedure. Life Sci., 65(26): 2781-2789.
23. Tajerzadeh H, Hamidi M, Dehpour A, Rouini M and Mehr S (2001). In vitro characterization of human inact erythrocytes loaded by Enalaprilat. Drug Delivery, 8: 223-230.
24. Tesconi S and Sepassi K (1999). Freeze drying above room temperature. J. Pharm. Sci., 88(5): 501-505.
25. Vyas SP, Jaitely V, Jain S, Venkatesan N and Kanaujia P (1986). Resealed erythrocytes: Drug carrier potentials and biomedical applications. Indian Drugs, 33(12): 589-594.
26. Vyas SP and Khar RK (2002). Targeted and controlled drug delivery - Novel carrier systems. CBS Publishes and Distributors, New Delhi, pp.387-415.
27. Wadke PA and Jacobson S (1980). Preformulation testing specific delivery of mitomycin C to the liver, spleen and lung; nano and microspherical carriers of gelatin. Int. J. Pharm., 81: 131-141.
28. Zolla G, Lupidi M, Marcheggiani G and Falcioni, Brunori M (1990). Encapsulation of proteins into human erythrocytes: a kinetic investigation. iochim. Biophys. Acta., 1024: 5-9. (Pubitemid 20145582)